Model | Low-dose group (N%) | Intermediate -dose group (N%) | High-dose group (N%) | ||||||
---|---|---|---|---|---|---|---|---|---|
(<=1.875mg/d) | (1.875~3.125mg/d) | (>=3.125mg/d) | |||||||
under | ideal | over | under | ideal | over | under | ideal | over | |
ANFISiv | 0 (0.0) | 1 (0.3) | 362 (98.7) | 5 (0.2) | 1645 (86.4) | 255 (13.4) | 467 (63.8) | 265 (36.2) | 0 (0.0) |
ANFISstra-iv | 1 (0.2) | 33 (9.1) | 329 (90.6) | 126 (6.6) | 1526 (80.1) | 253 (13.3) | 505 (69.0) | 227 (31.0) | 0 (0.0) |
ANFISev | 0 (0.0) | 0 (0.0) | 347 (100.0) | 5 (0.5) | 889 (86.1) | 139 (13.5) | 155 (59.8) | 104 (40.2) | 0 (0.0) |
ANFISstra-ev | 0 (0.0) | 18 (5.2) | 329 (94.8) | 79 (7.6) | 851 (82.4) | 103 (10.0) | 194 (74.9) | 65 (25.1) | 0 (0.0) |